Skip to content

The effect of lavender aromatherapy on primary dysmenorrhea in students of Tehran University of Medical Sciences dormitories

The effect of lavender aromatherapy on primary dysmenorrhea in students of Tehran University of Medical Sciences dormitories

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105086412N1
Enrollment
96
Registered
2012-08-25
Start date
2011-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhoea. Pain and other conditions associated with female genital organs and menstrual cycle

Interventions

Intervention 1: experimental group, Aromatherapy was applied in the form inhalation with using five drops of lavender in sesame oil. for 3 minutes every 6 hours, for two period, one day before the st
Treatment - Drugs
Placebo
experimental group, Aromatherapy was applied in the form inhalation with using five drops of lavender in sesame oil. for 3 minutes every 6 hours, for two period, one day before the start of menstruat
placebo group, Aromatherapy was applied in the form inhalation with using five drops of lavender in sesame oil. for 3 minutes every 6 hours, for two period, one day before the start of menstruation an

Sponsors

Research Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The selection criteria were: The risk of dysmenorrhea according to menstrual history; history from level 2 and 3 dysmenorrhea; no systemic disease or disease of the genital organs; no use of contraceptives; being single; had a normal sense of smell; None allergies to fragrances; regular menstrual cycles, had not been using analgesics to overcome dysmenorrhea.The exclusion criterion was allergy to lavender.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Primary dysmenorrhoea. Timepoint: Two months before the intervention and Two months after the intervention. Method of measurement: Multidimensional questionnaires grading scales and VAS scale.

Secondary

MeasureTime frame
Vomiting, nausea,,Tierdness/dizziness, Diarrhea, Mood change, Faint and Hot flushing and amount bleeding. Timepoint: 2 month befor intervention and 2 month after intervention. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZiba Raisi Dehkordi

Tehran University of Medical Scinces

zibard@skums,ac.ir+98 21 6692 7171

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026